General Information of the Compound
Compound ID |
CP0457679
|
||||||||||||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Compound Name |
Cloperastine
Show/Hide
|
||||||||||||||||||
Synonyms |
1-(2-((4-Chlorophenyl)(phenyl)methoxy)ethyl)piperidine hydrochloride
1-(2-((p-Chloro-alpha-phenylbenzyl)oxy)ethyl)piperidine hydrochloride
1-(2-(p-Cloro-alpha-fenilbenzilossi)etil)piperidina cloridrato [Italian]
14984-68-0
2-Piperidinoethyl p-chlorobenzhydryl ether hydrochloride
4-Chlorobenzhydryl 2-(1-Piperidyl)ethyl Ether Hydrochloride
Cloperastina cloridrato [Italian]
Cloperastine
Cloperastine HCl
Cloperastine hydrochloride
DSSTox_CID_25413
DSSTox_GSID_45413
DSSTox_RID_80863
EINECS 239-067-8
Q-200881
Seki
Show/Hide
|
||||||||||||||||||
Structure |
|
||||||||||||||||||
Formula |
C20H24ClNO
|
||||||||||||||||||
Molecular Weight |
329.871
|
||||||||||||||||||
Canonical SMILES |
Clc1ccc(cc1)C(OCCN1CCCCC1)c1ccccc1
Show/Hide
|
||||||||||||||||||
InChI |
InChI=1S/C20H24ClNO/c21-19-11-9-18(10-12-19)20(17-7-3-1-4-8-17)23-16-15-22-13-5-2-6-14-22/h1,3-4,7-12,20H,2,5-6,13-16H2
Show/Hide
|
||||||||||||||||||
InChIKey |
FLNXBVJLPJNOSI-UHFFFAOYSA-N
|
||||||||||||||||||
Physicochemical Property |
"RO5" indicates the cutoff set by lipinski's rule of five: (1) Molecular weight less than 500 Dalton; (2) xlogp less than 5; (3) No more than 5 hbonddonor (Hydrogen Bond Donor Count); (4) No more than 10 hbondacc (Hydrogen Bond Acceptor Count); (5) No more than 10 rotbonds (Rotatable Bond Count). Show/Hide
|
||||||||||||||||||
Click to Show/Hide the External Link(s) of This Compound | |||||||||||||||||||
PubChem ID | |||||||||||||||||||
ChEMBL ID | |||||||||||||||||||
DrugBank ID |
Map of Molecular Bioactivity Related to the Compound
Map of Molecular Bioactivity Related to the Compound Compound Cell Line Protein Bioactivity Value: <= 0.1 μM > 0.1 μM and <= 10 μM > 10 μM Imprecise Activity |
|
---|
Table of Molecular Bioactivities Related to the Compound
Clinical Information about the Compound